Literature DB >> 20943306

Thermodynamics of radicicol binding to human Hsp90 alpha and beta isoforms.

Asta Zubrienė1, Malgorzata Gutkowska, Jurgita Matulienė, Romanas Chaleckis, Vilma Michailovienė, Aliona Voroncova, Ceslovas Venclovas, Alicja Zylicz, Maciej Zylicz, Daumantas Matulis.   

Abstract

Radicicol is a natural antibiotic that specifically inhibits chaperone Hsp90 activity and binds to its active site with nanomolar affinity. Radicicol has been widely used as a lead compound to generate synthetic analogs with reduced toxicity and increased stability that could be employed clinically. Here we present a detailed thermodynamic description of radicicol binding to human Hsp90 and yeast Hsc82 studied by isothermal titration calorimetry and thermal shift assay. Titrations as a function of pH showed a linked protonation event upon radicicol binding. The intrinsic binding constant and the thermodynamic parameters (including the enthalpy, entropy, and heat capacity) were determined for yeast Hsc82, and human alpha and beta Hsp90. Recent experimental evidence in literature shows that yeast Hsc82 has significant differences from human Hsp90 isozymes. Here we support this by demonstrating differences in radicicol binding thermodynamics to these proteins. The intrinsic enthalpy of radicicol binding to Hsc82 was -46.7 kJ/mol, to Hsp90alpha -70.7 kJ/mol, and to Hsp90beta was -66.8 kJ/mol. The enthalpies of binding were significantly different, while the intrinsic dissociation constants were quite similar, equal to 0.25, 0.04, and 0.15 nM, respectively. The structural features responsible for such large difference in binding enthalpy but small difference in the intrinsic binding Gibbs free energy are discussed.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20943306     DOI: 10.1016/j.bpc.2010.09.003

Source DB:  PubMed          Journal:  Biophys Chem        ISSN: 0301-4622            Impact factor:   2.352


  7 in total

1.  Volume of Hsp90 ligand binding and the unfolding phase diagram as a function of pressure and temperature.

Authors:  Vytautas Petrauskas; Joana Gylytė; Zigmantas Toleikis; Piotras Cimmperman; Daumantas Matulis
Journal:  Eur Biophys J       Date:  2013-01-05       Impact factor: 1.733

2.  Structure-Based Design, Synthesis, and Biological Evaluation of Hsp90β-Selective Inhibitors.

Authors:  Subhabrata Chaudhury; Penchala Narasimharao Meka; Monimoy Banerjee; Caitlin N Kent; Brian S J Blagg
Journal:  Chemistry       Date:  2021-09-29       Impact factor: 5.236

3.  Hsp90 chaperones have an energetic hot-spot for binding inhibitors.

Authors:  Reyal S Hoxie; Timothy O Street
Journal:  Protein Sci       Date:  2020-09-08       Impact factor: 6.725

Review 4.  Paralog Specific Hsp90 Inhibitors - A Brief History and a Bright Future.

Authors:  Daniel T Gewirth
Journal:  Curr Top Med Chem       Date:  2016       Impact factor: 3.295

5.  The Development of Hsp90β-Selective Inhibitors to Overcome Detriments Associated with pan-Hsp90 Inhibition.

Authors:  Sanket J Mishra; Weiya Liu; Kristin Beebe; Monimoy Banerjee; Caitlin N Kent; Vitumbiko Munthali; John Koren; John A Taylor; Leonard M Neckers; Jeffrey Holzbeierlein; Brian S J Blagg
Journal:  J Med Chem       Date:  2021-01-11       Impact factor: 7.446

6.  Thermodynamics of aryl-dihydroxyphenyl-thiadiazole binding to human Hsp90.

Authors:  Egidijus Kazlauskas; Vilma Petrikaitė; Vilma Michailovienė; Jurgita Revuckienė; Jurgita Matulienė; Leonas Grinius; Daumantas Matulis
Journal:  PLoS One       Date:  2012-05-24       Impact factor: 3.240

7.  Structure-guided design of an Hsp90β N-terminal isoform-selective inhibitor.

Authors:  Anuj Khandelwal; Caitlin N Kent; Maurie Balch; Shuxia Peng; Sanket J Mishra; Junpeng Deng; Victor W Day; Weiya Liu; Chitra Subramanian; Mark Cohen; Jeffery M Holzbeierlein; Robert Matts; Brian S J Blagg
Journal:  Nat Commun       Date:  2018-01-30       Impact factor: 14.919

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.